ANI Pharmaceuticals (ANIP) Earnings Date, Estimates & Call Transcripts $63.93 +0.58 (+0.92%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$63.55 -0.38 (-0.59%) As of 08/1/2025 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANI Pharmaceuticals Earnings Summary ANI Pharmaceuticals released Q1 2025 earnings on May 9, 2025, reporting an EPS of $1.70, which topped analysts' consensus estimates of $1.37 by $0.33. Quarterly revenue rose 43.4% year-over-year to $197.12 million, above analyst estimates of $179.75 million. With a trailing EPS of -$1.27, ANI Pharmaceuticals' earnings are expected to grow 9.07% next year, from $3.86 to $4.21 per share. Upcoming Q2 Earnings DateAug. 8Before Market OpensEstimatedConsensus EPS (May. 9) $1.37 Actual EPS (May. 9) $1.70 Beat By $0.33 Actual Revenue (May. 9) $197.12MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)SEC FilingANIP Upcoming EarningsANI Pharmaceuticals' Q2 2025 earnings is scheduled for Friday, August 8, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get ANI Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ANI Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataANIP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANIP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. ANI Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20252$0.91$1.13$1.02Q2 20252$1.02$1.27$1.15Q3 20252$1.13$1.23$1.18Q4 20252$1.40$1.50$1.45 ANI Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/8/2025(Estimated)-------5/9/2025Q1 2025$1.37$1.70+$0.33$0.69$179.75M$197.12M11/8/2024Q3 2024$1.09$1.34+$0.25$3.35$144.37M$148.30M8/6/2024Q2 2024$0.95$1.02+$0.07$1.58$129.09M$138.00M5/10/2024Q1 2024$0.79$0.95+$0.16$1.08$125.01M$137.43M2/29/2024Q4 2023$0.58$0.78+$0.20$1.52$123.02M$131.65M11/8/2023Q3 2023$0.84$1.27+$0.43$1.65$111.92M$131.83M8/9/2023Q2 2023$0.64$1.28+$0.64$1.83$99.87M$116.50M ANI Pharmaceuticals Earnings - Frequently Asked Questions When is ANI Pharmaceuticals' earnings date? ANI Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on ANIP's earnings history. What guidance has ANI Pharmaceuticals issued on next quarter's earnings? ANI Pharmaceuticals issued an update on its FY 2025 earnings guidance on Saturday, June, 28th. The company provided earnings per share (EPS) guidance of 6.270-6.620 for the period, compared to the consensus earnings per share estimate of 6.340. The company issued revenue guidance of $768.0 million-$793.0 million, compared to the consensus revenue estimate of $769.6 million. Did ANI Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ANI Pharmaceuticals (NASDAQ:ANIP) reported $1.70 earnings per share (EPS) to beat the analysts' consensus estimate of $1.37 by $0.33. Learn more on analysts' earnings estimate vs. ANIP's actual earnings. How can I listen to ANI Pharmaceuticals' earnings conference call? The conference call for ANI Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read ANI Pharmaceuticals' conference call transcript? The conference call transcript for ANI Pharmaceuticals' latest earnings report can be read online. Read Transcript How can I view ANI Pharmaceuticals' earnings report? ANI Pharmaceuticals' earnings report can be found in their filing with the SEC. View SEC filing How much revenue does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded annual revenue of $614.38 million. How much profit does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded net income of -$18.52 million. ANIP has generated -$1.27 earnings per share over the last four quarters. What is ANI Pharmaceuticals' EPS forecast for next year? ANI Pharmaceuticals' earnings are expected to grow from $3.86 per share to $4.21 per share in the next year, which is a 9.07% increase. More Earnings Resources from MarketBeat Related Companies ADMA Biologics Earnings Date Annovis Bio Earnings Date Nuvalent Earnings Date CRISPR Therapeutics Earnings Date Rhythm Pharmaceuticals Earnings Date Lantheus Earnings Date Axsome Therapeutics Earnings Date Vaxcyte Earnings Date Merus Earnings Date Cytokinetics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NASDAQ:ANIP) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ANI Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
